Recent Finacing
Recent Raise
Optithera offers a saliva-based genomic test computing a ~600-variant polygenic risk score with clinical factors to predict diabetic complications, plans >2,500-patient validation, pursuing ISO 13485 and Canadian rollout.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
